Abstract
Five groups of linear biopolymers, composed of amino acid residues and called neuropeptides, are considered in this chapter. The primary structure of a prototype of each group is shown in Table 1. The sequences were initially identified in animals and subsequently all of them were also found in man.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ahmad S, Allescher HD, Kwan CY (1991) Receptors for neuropeptides: ligand-binding studies. In: Daniel EE (ed) Neuropeptide function in gastrointestinal tract. CRC, Boca Raton, pp 209–229
Allescher HD, Ahmad S (1991) Postulated physiological and pathophysiological roles in motility. In: Daniel EE (ed) Neuropeptide function in the gastrointestinal tract. CRC, Boca Raton, pp 309–400
Allescher HD, Kostolanska F, Tougas G, Fox JET, Regoli D, Drapeau D, Daniel EE (1989) The action of neurokinin and substance P receptors in canine pylorus, antrum and duodenum. Peptides 10:671–679
Altar CA, Boyar WC (1989) Brain CCK-B receptors mediate the suppression of dopamine release by cholecystokin. Brain Res 483:321–326
Anastasi A, Erspamer V, Endean R (1967) Isolation and structure of caerulein, an active decapeptide from the skin of Hyla coerulea. Experientia 23:699–703
Andersson KE, Andersson R, Hedner R (1972) Cholecystokinetic effect and concentration of cyclic AMP in gall bladder in vitro. Acta Physiol Scand 85:511–516
Aoki K, Kajiwara M, Oka T (1986) The inactivation of [Met5]-enkephalin by bestatin-sensitive aminopeptidase, captopril-sensitive peptidyl dipeptidase A and thiorphan-sensitive endopeptidase-24.11 in mouse vas deferens. Jpn J Pharmacol 40:297–302
Araki K, Tachibana S, Uchiyama M, Nakajima T, Yasuhara T (1973) Isolation and structure of a new active peptide “Xenopsin” on the smooth muscle especially on a strip of fundus from a rat stomach, from the skin of Xenopus laevis. Chem Pharm Bull (Tokyo) 21:2801–2804
Armstrong MJ, Parker MC, Ferris CF, Leeman SE (1986) Neurotensin stimulates (3H) oleic acid translocation across rat small intestine. Am J Physiol 251: G823–G829
Atkins HL, Oster ZH (1989) Asymetric gall bladder contraction following chol-ecystokinin hepatobiliary imaging. Chem Nucl Med 14:82–86
Barabé J, Park WK, Regoli D (1975) Application of drug-receptor theories to the analysis of the myotropic effects of bradykinin. Can J Physiol Pharmacol 53: 345–353
Bauer AJ, Szursweski JH (1989) Dynorphin presynaptically inhibits neuro muscular transmission via delta opioid receptors in circular muscle of canine duodenum (Abstr). Gastroenterology 96:A33
Behar J, Biancani P (1977) Effect of cholecystokinin octapeptide on lower esophageal sphincter. Gastroenterology 73:57–61
Behar J, Biancani P (1980) Effect of cholecystokinin and the octapeptide cholecystokinin on the feline sphincter of Oddi and gall bladder; Mechanism of action. J Clin Invest 66:1231–1239
Bennett A, Misiewicz JJ, Waller SL (1967) Analysis of the motor effect of gastrin and pentagastrin on the human alimentary tract in vitro. Gut 8:470–474
Bertaccini G (1976) Active polypeptides of non-mammalian origin. Pharmacol Rev 28:127–177
Bertaccini G, Erspamer V, Impicciatore H (1973) The actions of bombesin on gastric secretion of the dog and rat. Br J Pharmacol 49:437–444
Bertaccini G, Erspamer V, Melchiorri P, Sopranzi N (1974) Gastrin release by bombesin in the dog. Br J Pharmacol 52:219–225
Bitar KN, Burgess GM, Putney JW Jr, Makhlouf GM (1986) Source of activator calcium in isolated guinea pig and human gastric smooth muscle cells. Am J Physiol 250.G280
Blundell J (1991) Pharmacological approaches to appetite suppression. Trends Pharmacol Sci 12:147–157
Borison HL (1971) Sites of action of narcotic analgesic drugs: the nervous system. In: Clouet DE (ed) Narcotic drugs: biochemical pharmacology. Plenum, New York
Borson DB (1991) Roles of neutral endopeptidases in airways. Am J Physiol 260: L212–L225
Brizzolara A, Burnstock G (1991) Endothelium dependent and endothelium independent vasodilatation of the hepatic artery of the rabbit. Br J Pharmacol 103:1206–1212
Brown MR, River J, Vale WW (1977) Bombesin: potent effect on thermoregulation in the rat. Science 196:988–990
Brown MR, Taché Y, Fisher D (1979) Central nervous system action of bombesin: mechanism to induce hyperglycemia. Endocrinology 105:660–665
Bunnet NW, Reeve JR, Walsh JH (1983) Catabolism of bombesin in the interstitial fluid of the rat stomach. Neuropeptides 4:55–64
Bunnet NW, Kobayashi R, Orloff MS, Reeve JR, Turner AJ, Walsh JH (1985) Catabolism of gastrin-releasing peptide and substance P by gastric membrane- bound peptidases. Peptides 6:277–283
Burnstock G (1970) Structure of smooth muscle and its innervation. In: Bulbring E, Brading A, Jones A, Tomita T (eds) Smooth muscle. Arnold, London, pp 1–69
Busse R, Mulsch A (1990) Calcium-dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin. FEBS Lett 265:133–134
Cameron AJ, Phillips SF, Summerskill WHJ (1967) Effect of cholecystokinin on motility of human stomach and gall bladder muscle in vitro. Clin Res 15:416
Campbell C, Phillips DC, Frazier TM (1961) Analgesia during labor: a comparison of pentobarbital, meperidine and morphine. Obstet Gynecol 17:714–718
Cantor P, Holst JJ, Knuhtsen S, Rehfeld JF (1987) Effect of neuroactive agents in cholecystokinin release from the isolated perfused porcine duodenum. Acta Physiol Scand 130:627–632
Caprilli R, Melchiorri P, Improta G, Vernia P, Fried G (1975) Effects of bombesin and bombesin-like peptides on gastrointestinal myoelectric activity in the dog. Gastroenterology 68:1228–1235
Carraway RE, Leeman SE (1973) The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J Biol Chem 248:6854–6861
Carraway RE, Leeman SE (1975) Structural requirements for the biological activity of neurotensin, a new vasoactive peptide. In: Walter R, Meienhofer J (eds) Peptide chemistry, structure and biology. Ann Arbor Sci, Ann Arbor, p 679
Carraway RE, Cochrane DE, Lansoman JB, Leeman SE, Paterson BM, Welch HJ (1982) Neurotensin stimulates exocytic histamine secretion from rat mast cells and elevates plasma histamine levels. J Physiol (Lond) 323:404–414
Chang MM, Leeman SE (1970) Isolation of a sialogogic peptide from bovine hypothalamic tissue and its characterization as substance P. J Biol Chem 245:4784–4790
Chang RS, Lotti VJ (1986) Biochemical and pharmacological characterization of a new extremely potent and selective non peptide cholecystokinin antagonist. Proc Natl Acad Sci USA 83:4923–4926
Chang RS, Lotti VJ (1988) A review of the biological and pharmacological characterization of a highly peripherally selective CCK antagonists L-364;718. In: Wang RY, Schoenfeld R (eds) Cholescytokinin Antagonists. Liss, New York, pp 13–28
Chang RS, Lotti VJ (1991) Ligands for cholecystokinin A and choecystokinin B/gastrin receptors. In: Conn PM (ed) Methods in neurosciences. Academic, Orlando, 5:479–493
Checler F (1991) Peptidases and neuropeptide-inactivating mechanisms in the circulation and gastrointestinal tract. In: Daniel EE (ed) Neuropeptide function in the gastrointestinal tract. CRC, Boca Raton, pp 273–307
Checler F, Kostolanska B, Fox JET (1988) In vivo inactivation of neurotensin in dog ileum: major involvement of endopeptidase 24–11. J Pharmacol Exp Ther 244:1040–1044
Cheng YC, Prusoff WH (1973) Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099–3108
Cherubini E, North RA (1985) Mu and kappa opioids inhibit transmitter release by different mechanisms. Proc Natl Acad Sci USA 82:1860–1863
Chowdhury JR, Berkowitz JM, Praissman M, Fara JW (1975) Interaction between octapeptide cholecystokinin, gastrin and secretin on cat gall bladder in vitro. Am J Physiol 229:1311–1315
Christinck F, Daniel EE, Fox JET (1989) Electrophysiological responses of canine ileal circular muscle to electrical stimulation and neurotensin (NT) (Abstr). Gastroenterology 96:A680
Clark WG (1981) Effects of opioid peptides on thermoregulation. Fed Proc 40: 2754–2759
Cohen ML, Geary LE, Wiley KS (1983) Enkephalin degradation in the guinea pig ileum: effect of aminopeptidase inhibitors, puromycin and bestatin. J Pharmacol Exp Ther 224:379–385
Constantine JW, Lebel WS, Woody HA (1990) Smooth muscle of rabbit isolated aorta contains the NK-2 tachykinin receptor. Naunyn Schmiedebergs Arch Pharmacol 342:722–724
Cotton R, Giles MG, Miller L, Shaw JS, Timms D (1984) ICI 174864: a highly-selective antagonist for the opioid δ-receptor. Eur J Pharmacol 97:331–332
Couture R, Cuello AC (1984) Plasma protein extravasation induced by mammalian tachykinins in the rat skin: influence of anaesthetic agents and an acetylcholine antagonist. Br J Pharmacol 91:265–273
Couture R, Regoli D (1982) Smooth muscle pharmacology of substance P. Pharmacology 24:1–25
Couture R, Mizrahi J, Regoli D, Devroede G (1981) Peptides and the human colon: an in vitro pharmacological study. Can J Physiol Pharmacol 59:957–964
Couture R, Laneuville O, Guimond C, Drapeau G, Regoli D (1989) Characterization of the peripheral action of neurokinins and neurokinin receptor selective agonists on the rat cardiovascular system. Naunyn Schmiedebergs Arch Pharmacol 340:547–557
Crawley JN (1991) Cholecystokinin-dopamine interactions. Trends Pharmacol Sci 12:232–236
Crochelt RF, Peikin SR (1986) Characterization of Ca channels mediating gall bladder contraction in the guinea pig (Abstr). Gastroenterology 90:1787
Crossman DC, Larkin S, Fuller RW, Davies GJ, Maseri A (1989) Substance P dilates epicardial coronary arteries and increases coronary blood flow in humans. Circulation 80:475–484
D’Orléans-Juste P, Dion S, Mizrahi J, Regoli D (1985) Effects of peptides and nonpeptides on isolated arterial smooth muscles: role of endothelium. Eur J Pharmacol 114:9–21
D’Orléans-Juste P, Dion S, Drapeau G, Regoli D (1986) Different receptors are involved in the endothelium-mediated relaxation and the smooth muscle contraction of the rabbit pulmonary artery in response to substance P and related neurokinins. Eur J Pharmacol 125:37–44
De Montigny C (1989) Cholecystokinin tetrapeptide induces panick attacks in healthy volunteers: preliminary findings. Arch Gen Psychiatry 46:511–517
Deblois D, Marceau F (1987) The ability of des-Arg9-bradykinin to relax rabbit isolated mesenteric arteries is acquired during in vitro incubation. Eur J Pharmacol 142:141–144
Dion S, D’Orléans-Juste P, Drapeau G, Rhaleb NE, Rouissi N, Tousignant C, Regoli D (1987) Characterization of neurokinin receptors in various isolated organs by the use of selective agonists. Life Sci 41:2269–2278
Dion S, Corcos J, Carmel M, Drapeau G, Regoli D (1988) Substance P and neurokinins as stimulants of the human isolated urinary bladder. Neuropeptides 11:83–87
Dobner PR, Barber DL, Villa-Komaroff L, McKiernan C (1987) Cloning and sequence analysis of cDNA from the canine neurotensin/neuromedin N precursor. Proc Natl Acad Sci USA 84:3516–3520
Dockray GJ, Dimaline R, Pauwels S, Varro A (1989) Gastrin and CCK-related peptides. In: Martinez J (ed) Peptide hormones and prohormones. Harwood, Chichester, pp 244–284
Dourish CT, Hawley D, Iversen SD (1988) Enhancement of morphine analgesia and prevention of morphine tolerance in the rat by cholecystokinin antagonist L 364 718. Eur J Pharmacol 147:469–472
Drapeau G, Rouissi N, Nantel F, Rhaleb NE, Tousignant C, Regoli D (1990) Antagonists for the neurokinin NK-3 receptor evaluated in selective receptor systems. Regul Pept 31:125–135
Edkins JS (1905) On the chemical mechanism of gastric secretion. Proc R Soc Lond [B] 76:376
Ekblad E, Hakanson R, Sundler F (1991) Microanatomy and chemical coding of peptide containing neurons in the digestive tract. In: Daniel EE (ed) Neuropeptide function in the gastrointestinal tract. CRC, Boca Raton, pp 131–179
Eng J, Shiina Y, Pan YC, Blacher R, Chang M, Stein S, Yalow R (1983) Pig brain contains cholecystokinin octapeptide and several cholecystokinin desoct-apeptides. Proc Natl Acad Sci USA 80:6381–6385
Erspamer V, Melchiorri P (1980) Active polypeptides: from amphibian skin to gastrointestinal tract and brain of mammals. Trends Pharmacol Sci 1:391–395
Erspamer V, Falconieri Erspamer G, Inselvini M (1970) Some pharmacological actions of alytesin and bombesin. J Pharm Pharmacol 22:875–876
Erspamer V, Falconieri-Erspamer G, Inselvini M, Negri L (1972) Occurence of bombesin and alytesin in extracts of the skin of three European discoglossid frogs and pharmacological actions of bombesin on extravascular smooth muscle. Br J Pharmacol 45:333–348
Erspamer V, Improta G, Melchiorri P, Sopranzi N (1974) Evidence of cholecystokinin release by bombesin in dog. Br J Pharmacol 52:227–232
Eysselein VE, Reeve JR Jr, Shively JE, Miller C, Walsh JH (1984) Isolation of a large cholecystokinin precursor from canine brain. Proc Natl Acad Sci USA 81:6565–6568
Falconieri-Erspamer G, Serverini C, Erspamer V, Melchiorri P, Dellefave G, Nakajima J (1988) Parallel bioassay of 27 bombesin like peptides on 9 smooth muscle preparations. Structure-activity relationships and bombesin receptor subtypes. Regul Pept 21:1–11
Fox JET, Daniel EE (1986) Substance P a potent inhibitor of the canine small intestine in vivo. Am J Physiol 250:G21–G27
Frazer HF, Nash TL, Vanhorn GD, Isbell M (1954) Use of miotic effect in evaluating analgesic drugs in man. Arch Int Pharmacodyn Ther 98:443–451
Friedlinger RM (1989) Nonpeptide ligands for peptide receptors. Trends Pharmacol Sci 10:270–274
Fukuda H, Hosoki E, Ishida Y, Moritoki H (1985) Opioids receptor types on adrenergic nerve terminals of rabbit ear artery. Br J Pharmacol 86:539–545
Furchgott RF (1981) The requirement of endothelial cells in the relaxation of arteries by acetylcholine and some other vasodilators. Trends Pharmacol Sci 3:173–175
Furness JB, Costa M (1987) The enteric nervous system. Churchill Livingstone, Edinburgh
Gafford JT, Skidgel RA, Erdos EG, Hersh LBC (1983) Human kidney “en-kephalinase”, a neutral metalloendopeptidase that cleaves active peptides. Biochemistry 22:3265–3271
Gen MC, Valdman AV (1967) Experimental observations on the pharmacology of the pontine respiration center. Prog Brain Res 20:148–170
Gerner T, Haffner JFW (1977) The role of local cholinergic pathways in the motor responses to cholecystokinin and gastrin in isolated guinea pig fundus and antrum. Scand J Gastroenterol 12:751–757
Gibbs J, Fauser DJ, Rowe EA, Rolls BJ, Rolls ET, Maddison SP (1979) Bombesin suppresses feeding in rats. Nature 282:208–210
Gilbert PE, Martin WR (1976) The effects of morphine and nalorphine-like drugs in the non-dependent, morphine-dependent and cycazocine-dependent chronic spinal dog. J Pharmacol Exp Ther 198:66–82
Gillan MG, Kosterlitz HW, Magnan J (1981) Unexpected antagonism in the rat vas deferens by benzo-morphans which are agonists in other pharmacological tests. Br J Pharmacol 72:13–15
Gintzler AR, Scalisi JA (1982) Effects of opioids on non-cholinergic excitatory responses of the guinea pig isolated ileum: inhibition of the release of enteric substance P. Br J Pharmacol 75:199–205
Girard F, Bachelard H, St-Pierre S, Rioux F (1984) The contractile effect of bombesin, gastrin releasing peptide and various fragments in the rat stomach strip. Eur J Pharmacol 102:489–497
Goedert M, Hunter JC, Ninkovic M (1984) Evidence for neurotensin as a non-adrenergic, non-cholinergic neurotransmitter in guinea pig ileum. Nature 311:59–62
Green J, Nunley C, Anderson NG (1966) High-pressure column chromatography. I. Design of apparatus and separation of bases, nucleosides and nucleotides. Natl Cancer Inst Monogr 21:431–440
Gridger JR, Makhlouf GM (1987) Regional and cellular heterogeneity of CCK receptors mediating muscle contraction in the gut. Gastroenterology 92:175–180
Grundy HF (1971) Cardiovascular effects of morphine, pethidine, dismorphine and nalorphine on the cat and rabbit. Br J Pharmacol 42:159–178
Guard S, Watson SP (1991) Tachykinin receptor types: classification and membrane signaling mechanisms. Neurochem Int 18:149–165
Gulati N, Mathison R, Huggel H, Regoli D, Beny JL (1987) Effects of neurokinins on the isolated pig coronary artery. Eur J Pharmacol 137:149–154
Guo YS, Singh P, Lluis F, Gomez G, Thompson JC (1986) Contractile response of gallbladder and sphincter of Oddi to substance P and related peptides compared to CCK-8 (Abstr). Fed Proc 45:291
Hammer RA, Leeman SE, Carraway R, Williams RH (1980) Isolation of human intestinal neurotensin. J Biol Chem 255:2476–2480
Hanko JM, Hardebeo JE (1978) Enkephalin-induced dilatation of pial arteries probably mediated by opiate receptors. Eur J Pharmacol 51:295–297
Harper AA, Raper HS (1943) Pancreazymin, a stimulant of the secretion of pancreatic enzymes in extracts of the small intestine. J Physiol (Lond) 102:115–125
Heimbrook DC, Saari WS, Balishin NL, Friedman A, Moore KS, Riemen MW, Kiefer DM, Rotberg NS, Wallen JW, Oliff A (1989) Carboxyl-terminal modification of a gastrin derivative generates potent antagonists. J Biol Chem 264: 11258–11262
Heike CJ, Krause JE, Mantyh PW, Couture R, Bannon MJ (1990) Diversity in mammalian tachykinin peptidergic neurons: multiple peptides, receptors and regulatory mechanisms. FASEB J 4:1606–1615
Hökfelt T (1986) Coexistence of neuronal messengers: a new principle in chemical transmission. In: Fuxe K, Pernow B (eds) Progress in brain research, 68, Elsevier, Amsterdam
Hökfelt T, Herrera-Marschitz M, Seroogy K, Ju G, Staines WA, Holets V, Schalling M, Ungerstedt U, Post C, Rehfeld JF (1988) Immunohistochemical studies on cholecystokinin (CCK)-immunoreactive neurons in the rat using sequence specific antisera and with special reference to the candate nucleus and primary sensory neurons. J Chem Neuroanat 1:11–51
Hua X, Lundberg JM, Theodorsson-Norheim E, Brodin E (1984) Comparison of cardiovascular and bronchosonstrictor effects of substance P, substance P, substance K and other tachykinins. Naunyn Schmiedebergs Arch Pharmacol 328: 196–201
Hughes J, Smith TW, Kosterlitz HW, Fathergill LH, Morgan BA, Morris HR (1975) Identification of two related pentapeptides from the brain with potent opioid agonist activity. Nature 258:577–580
Ignarro LJ (1989) Endothelium-derived nitric oxide actions and properties. FASEB J 3:31–36
Innis RB, Snyder SH (1980) Distinct cholecystokinin receptors in brain and pancreas Proc Natl Acad USA 77:6917–6921
Ireland SJ, Hagan RM, Bailey F, Jordan CC, Stephens-Smith ML (1990) Receptors mediating neurokinin-induced contractions of the guinea-pig trachea. Br J Pharmacol 99.63P
Ireland SJ, Bailey F, Cook A, Hagan RM, Jordan CC, Stephens-Smith ML (1991) Receptors mediating tachykinin-induced contractile responses in guinea pig trachea. Br J Pharmacol 103:1463–1469
Isenberg JI, Cseudes A (1972) Effect of octapeptide of cholecystokinin on canine pyloric pressure. Am J Physiol 222:428–431
Ivy AC, Oldberg E (1928) A hormone mechanism for gallbladder contraction and evacuation. Am J Physiol 65:599–613
Jensen RT, Coy DH (1991) Progress in the development of potent bombesin receptor antagonists. Trends Pharmacol Sci 12:13–19
Jensen RT, Jones SW, Folkers K, Gardner JD (1984) A synthetic peptide that is a bombesin-receptor antagonist. Nature 309:61–63
Jensen RT, Coy DH, Saeed ZA, Heinz-Erian P, Montey S, Gardner JD (1988) Interaction of bombesin and related peptides with receptors on pancreatic acinar cells. Ann NY Acad Sci 547:138–149
Jessell TM, Iversen LL (1977) Opiates analgesics inhibit substance P release from rat trigeminal nucleus. Nature 268:549–551
Jorpes JE, Mutt V (1968) Structure of porcine cholecystokinin-pancreozymin. I. Cleavage with thrombin and with trypsin. Eur J Biochem 6:156–162
Kakidani H, Furutani Y, Takahashi H, Noda M, Morimoto Y, Hirose T, Asai M, Inayama S, Nakanishi S, Numa S (1982) Cloning and sequence analysis of cDNA for porcine β-noe endorphine/dynorphin precursor. Nature 298:245–249
Kataoka K, Taniguchi A, Shimizu H, Sods D, Okumo S, Yajima H, Kitawaga K (1978) Biological activity of neurotensin and its C-terminal partial sequences. Brain Res Bull 3:555–557
Kimura I, Kimura M, Nakayama N, Kimura M (1983) Relaxation and Ca spike suppression in circular and longitudinal muscles of hog bile duct ampulla by CCK-C-terminal peptide. Arch Int Pharmacodyn 265:320–334
Kimura I, Kondoh T, Kimura M (1989) Effects of tetrodotoxin on relaxation of pig duodenal circular muscle induced by C-terminal fragments of cholecystokinin. Br J Pharmacol 96:739–745
Kislauskis E, Bullock B, McNeil S, Dobner PR (1988) The rat gene encoding neurotensin and neuromedin. J Biol Chem 263:4963–4968
Kitabgi P, Freychet P (1978) Effects of neurotensin on isolated intestinal smooth muscles. Eur J Pharmacol 50:349–357
Kitabgi P, Vincent JP (1981) Neurotensin is a potent inhibitor of guinea pig colon contractile activity. Eur J Pharmacol 74:311–318
Kitabgi P, Carraway R, Leeman SE (1976) Isolation of a tridecapeptide from bovine intestine tissue and its partial characterization as neurotensin. J Biol Chem 251:7053–7058
Kostka P (1991) Gastrointestinal neuropeptides and second messenger systems. In: Daniel ED (ed) Neuropeptide function in the gastrointestinal tract. CRC, Boca Raton, pp 249–271
Kotani H, Hoshimaru M, Nawa H, Nakanishi S (1986) Structure and gene organization of bovine neuromedin K precursor. Proc Natl Acad Sci USA 83:7074–7078
Krane IM, Naylor SL, Helin-Davis D, Chin WW, Spindel ER (1988) Molecular cloning of cDNAs encoding the human bombesin-like peptide neuromedin B. J Biol Chem 263:13317–13323
Laneuville O, Dorais J, Couture R (1988) Characterization of the effects produced by neurokinins and three agonists selective of neurokinin receptor subtypes in a spinal nocieptive reflex of the rat. Life Sci 42:1295–1305
Laufer R, Wormser V, Friedman ZY, Gilon C, Chorev M, Selinger Z (1985) Neurokinin B is a prefered agonist for a neuronal substance P receptor and its action is antagonized by enkephalins. Proc Natl Acad Sci USA 82:7444–7448
Laws PY, Hom DS, Loh HH (1983) Opiate regulation of adenosine 31:51-cyclic monophosphate level in neuroblastoma x glioma NG 108-15 hybrid cells. Relationship between receptor occupancy and effect. Mol Pharmacol 23:26–35
Lee HK, Wang SC (1975) Mechanism of morphine-induced miosis in the dog. J Pharmacol Exp Ther 192:415–431
Lefkowitz RJ, Kobilka BK, Caron MG (1989) The new biology of drug receptors. Biochem Pharmacol 38:2941–2948
Lehy T, Accary JP, Labeille D, Dubrasquet M (1983) Chronic administration of bombesin stimulates antral gastric cell proliferation in rat. Gastroenterology 84:914–919
Lemaire S, Magnan J, Regoli D (1978) Rat vas deferens: a specific bioassay for endogenous opioid peptides. Br J Pharmacol 64:327–329
Lhoste E, Aprahamian M, Pousse A, Hoeltzel A, Stock-Damgé C (1985) Trophic effect of bombesin on the rat pancreas: is it mediated by the release of gastrin or cholecystokinin? Peptides 6:89–97
Li Ch, Chung D (1976) Isolation and structure of an untriakonta peptide with opiate activity from camel pituitary glands. Proc Natl Acad Sci USA 73:1145–1148
Liston DR, Vanderhaeghen JJ, Rossier J (1983) Presence in brain of synenkephalin, a proenkephalin-immunoreactive protein which does not contain enkephalin. Nature 302:62–65
Lord JAH, Waterfield AA, Hughes J, Kosterlitz HW (1977) Endogenous opioid peptide: multiple agonists and receptors. Nature 267:495–499
Lotti VJ, Pendleton RG, Gould RJ, Hanson HM, Chang RSL, Clineschmidt BV (1987) In vivo pharmacology of L-364.718, a new potent non peptide peripheral cholecystokinin antagonist. J Pharmacol Exp Ther 241:103–109
Maggi CA, Giuliani S, Santiciolli P, Abelli L, Regoli D, Meli A (1987a) Further studies on the mechanism of the tachykinin-induced activation of micturition reflex in rats: evidence for the involvement of the capsaicin-sensitive bladder mechanoreceptors. Eur J Pharmacol 136:189–205
Maggi CA, Giuliani S, Santicioli P, Regoli D, Meli A (1987b) Peripheral effects of neurokinins: functional evidence for the existence of multiple receptors. J Auton Pharmacol 7:11–32
Maggi CA, Patacchini R, Giuliani S, Rovero P, Dion S, Regoli D, Giachetti A, Meli A (1990) Competitive antagonists discriminate between NK2 tachykinin receptor subtypes. Br J Pharmacol 100:583–592
Maggi CA, Patacchini R, Astolfi M, Rovero P, Giuliani S, Giachetti A (1991) NK-2 receptor agonists and antagonists. Ann NY Acad Sci 632:184–191
Marshall FH, Barnes S, Hughes J, Woodruff GN, Hunter JC (1991) Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms. J Neurochem 56:917–922
Martin WR (1967) Opioid antagonists. Pharmacol Rev 19:463–521
Martin WR (1984) Pharmacology of opioids. Pharmacol Rev 35:283–323
Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE (1976) The effects of morphine and neomorphine-like drugs in the non-dependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 197:517–532
Mastrangelo D, Mathison R, Huggel HJ, Dion S, D’Orléans-Juste P, Rhaleb NE, Drapeau G, Rovero P, Regoli D (1987) The rat isolated portal vein: a preparation sensitive to neurokinins, particularly neurokinin B. Eur J Pharmacol 134:321–336
Masu Y, Nakayama K, Tamaki H, Harada Y, Kuno M, Nakanishi S (1987) cDNA cloning of bovine substance K receptor through oocyte expression system. Nature 329:836–838
McClane TK, Martin WR (1967) Antagonism of the spinal cord effects or morphine and cyclazocine by naloxone and thebaine. Int J Neuropharmacol 6:325–327
McDonald TJ, Jörnvall H, Nilsson G, Vagne M, Ghatei M, Bloom SR, Mutt V (1979) Characterization of gastrin-releasing peptide from porcine non antral gastric tissue. Biochem Biophys Res Commun 90:227–233
McDonald TJ (1991) Gastroenteropancreatic regulatory peptide structures: an overview. In: Daniel EE (ed) Neuropeptide function in the gastrointestinal tract. CRC, Boca Raton, pp 19–86
McGilliard KL, Takemori AE (1978) Antagonism by naloxone of narcotic-induced respiratory depression and analgesia. J Pharmacol Exp Ther 207:494–503
McQueen DS (1983) Opioid peptide interactions with respiratory and circulatory systems. Br Med Bull 39:77–82
McRoberts JW (1986) Cholecystokinin and pain: a review. Anesth Prog 33:87–90
Merrifield RB (1963) Solid-phase peptide synthesis. I. The synthesis of a tetrapeptide. J Am Chem Soc 85:2149–2152
Miller LJ, Jardine I, Weissman E, Go VL, Speicher D (1984) Characterization of cholecystokinin from the human brain. J Neurochem 43:835–840
Milligan G, Streaty RA, Gierschik P, Spiegel AM, Klee WA (1987) Development of opiate receptors and GTP-binding regulatory proteins in neonatal rat brain. J Biol Chem 262:8626–8630
Minamino N, Kangawa K, Matsuo H (1983) Neuromedin B: a novel bombesin-like peptide identified in porcine spinal cord. Biochem Biophys Res Commun 114: 541–548
Minamino N, Kangawa K, Matsuo H (1984a) Neuromedin N: a novel neurotensinlike peptide identified in porcine spinal cord. Biochem Biophys Res Commun 122:542–549
Minamino N, Kangawa K, Matsuo H (1984b) Neuromedin C: a bombesin-like peptide identified in porcine spinal cord. Biochem Biophys Res Commun 119: 14–20
Mizrahi J, Dion S, D’Orléans-Juste P, Regoli D (1985) Activities and antagonism of bombesin on urinary smooth muscles. Eur J Pharmacol 111:339–345
Morgan JP, Morgan KG (1982) Vascular smooth muscle: the first recorded Ca2+ transients Pflugers Arch 395:75–77
Morgan KG, Szurszewski JH (1980) Mechanisms of phasic and tonic actions of pentagastrin on gastric smooth muscle. J Physiol (Lond) 301:229–242
Morgan-Boyd R, Stewart JM, Vavrek RJ, Hassis A (1987) Effects of bradykinin and angiotensin II intracellular Ca2+ dynamics in endothelial cells. Am J Physiol 253:C588–C598
Morley JE (1980) The neuroendocrine controls of appetite: the role of endogenous opiates, cholecystokinin, TRH, gamma-amino-butiric acid and diazepam receptors. Life Sci 27:355–368
Mosberg HI, Hurst R, Hruby VG, Gee K, Yamamura HI, Galligan JJ, Burks PF (1983) Bispenicillamine enkephalins possess highly-improved specificity towards δ opioid receptors. Proc Natl Acad Sci USA 80:5871–5874
Mousli M, Bueb JL, Bronner C, Rouot B, Landry Y (1990) G-protein activation: a receptorindependent mode of action for cationic amphilic neuropeptides and venom peptides. TIPS 11:358–362
Muallem S, Pandol SJ, Beeker TG (1989) Hormone-evoked calcium release from intracellular stores is a quantal process. J Biol Chem 264:205–212
Mudge AW, Leeman SE, Fischbach GD (1979) Enkephalin inhibits release of substance P from sensory neurons in culture and decreases action potential duration. Proc Natl Acad Sci USA 76:526–530
Murphy RB, Smith GP, Gibbs J (1987) Pharmacological examination of CCK-8-induced contractile activity in the rat isolated pylorus. Peptides 8:127–134
Mutt V (1983) New approaches to the identification and isolation of hormonal polypeptides. Trends Neurosci 6:357–360
Mutt V (1988) Secretin and cholecystokinin. In: Mutt V (ed) Gastrointestinal hormones, vol 2. Academic, New York, p 251
Nakajima T, Tanimura T, Pisano JJ (1970) Isolation and structure of a new vasoactive peptide (Abstr) Fed Proc 29:282
Nakanishi S (1986) Structure and regulation of the preprotachykinin gene. Trends Neurosci 9:41–44
Naline E, Devillier P, Drapeau G, Toty L, Bakdach H, Regoli D, Advenier C (1989) Characterization of neurokinins effects and receptor selectivity in human isolated bronchi. Am Rev Respir Dis 140:679–686
Nantel F, Rouissi N, Rhaleb NE, Dion S, Drapeau G, Regoli D (1990) The rabbit jugular vein is a contractile NK-1 receptor system. Eur J Pharmacol 179:457–462
Nantel F, Rouissi N, Rhaleb NE, Jukic D, Regoli D (1991) Pharmacological evaluation of the angiotensin, kimin and neurokinin receptors on the rabbit vena cava. J Cardiovasc Pharmacol 18:398–405
Nau R, Schafer G, Deacon CF, Cole T, Agaston DV, Conlon JM (1986) Proteolytic inactivation of substance P and neurokinin A in the longitudinal muscle layer of guinea pig small intestine. J Neurochem 47:856–864
Nawa H, Hirose T, Takashima H, Inayama S, Nakanishi S (1983) Nucleotide sequences of cloned cDNAs for two types of bovine brain substance P precursor. Nature 306:32–36
Negri L (1986) Satiety and scratching effects of bombesin-like peptides. Eur J Pharmacol 132:207–212
Nemeroff CB (1980) Neurotensin: perchance an endogenous neuroleptic? Biol Psychiatry 15:283–302
Nemeroff CB, Osbahr AJ, Manberg PJ, Ervin GN, Prange AJ (1979) Alteration in nociceptive and body temperature after intracisternally-administered neurotensin, β-endorphine, other endogenous peptides and morphine. Proc Natl Acad Sci USA 76:5368–5371
Nemeroff CB, Binette G, Manberg PJ, Osbahr AJ, Breese GR, Prange AJ (1980) Neurotensin induced hypothermia: evidence for an interaction with dopaminergic system and the hypothalamic-pituitary-thyroid axis. Brain Res 195:69–84
North RA, Williams JT (1985) On the potassium conductance increased by opioids in rat locus coeruleus neurones. J Physiol (Lond) 364:265–280
North RA, Williams JT, Surprenant A, Christie MJ (1987) μ and δ receptors belong to a family of receptors that are coupled to potassium channels. Proc Natl Acad Sci USA 84:5487–5491
Ohkawa H, Watanabe M (1977) Effect of gastrointestinal hormones on the electrical and mechanical activities on cat small intestine. Jpn J Physiol 27:271–279
Oka T, Negishi K, Suda M, Matsumiya T, Inazu T, Ueki M, Vekimasaaki V (1980) Rabbit vas deferens: a specific bioassay for opioid K-receptor agonists. Eur J Pharmacol 73:235–236
Opmeer FA, Peter J, Burbach H, Wiegant VM, Van Ree JM (1982) β-endorphin proteolysis by guinea pig ileum myenteric plexus membranes: increased γ-endorphin turnover after chronic exposure to morphine. Life Sci 31:323–328
Orloff MS, Reeve JR, Ben Avram C, Shively JE, Walsh JH (1984) Isolation and sequence analysis of human bombesin-like peptides. Peptides 5:865–870
Pandol SJ, Schoeffield MS, Sachs G, Muallem S (1985) Role of free cytosolic calcium in secretagogue-stimulated anylase release from dispersed acini from guinea pig pancreas. J Biol Chem 260:10081–10086
Patacchini R, Astolfi M, Quartara L, Rovero P, Giachetti A, Maggi CA (1991) Further evidence for the existence of NK-2 tachykinin receptor subtypes. Br J Parmacol 104:91–96
Paton WDM (1957) The action of morphine and related substances on contraction and on acetylcholine output of coaxially stimulated guinea pig ileum. Br J Pharmacol 12:119–127
Pelton JT, Gulya K, Hruby VG, Duckies SP, Yamamura HI (1985) Comformationally restricted analogues of somatostatin with high μ opioid receptor specificity. Proc Natl Acad Sci USA 82:236–239
Pendleton RG, Bendesky RJ, Schaffer L, Nolan TE, Gould RJ, Clineschmidt BV (1987) Roles of endogenous cholecystokinin in biliary, pancreatic and gastric function: studies with L-364-718 specific cholecystokinin receptor antagonist. J Pharmacol Exp Ther 241:110–116
Polak JM, Hamid, Springall DR, Cuttita F, Spindel E, Ghatei MA, Bloom SR (1988) Localization of bombesin-like peptides in tumors. Ann NY Acad Sci 547:322–335
Portoghese PS, Takemori AE (1985) TENA, a selective κ opioid receptor antagonist. Life Sci 36:801–805
Powell DW (1981) Muscle or mucosa: the site of action of antidiarrheal opiates? Gastroenterology 80:406–408
Pozo MJ, Salido GM, Madrid JA (1989) Cholecystokinin-induced gall bladder contraction is influenced by nicotinic acid and muscarinic receptors. Arch Int Physiol Biochim 97:403–408
Prange A, Nemeroff CB (1982) The manyfold actions of neurotensin: a first synthesis. Am NY Acad Sci 400:368–375
Quirion R, Rioux F, Regoli D, St-Pierre S (1979) Neurotensin-induced coronary vessel constriction in perfused rat hearts. Eur J Pharmacol 55:221–223
Quirion R, Regoli D, Rioux F, St-Pierre S (1980a) Structure activity studies with neurotensin: analysis of positions 9, 10 and 11. Br J Pharmacol 69:689–692
Quirion R, Rioux F, Regoli D, St-Pierre S (1980b) Compound 48/80 inhibits neurotensin-induced hypotension in rats. Life Sci 27:1889–1895
Rakovska A, Milenov K, Yanev S (1986) Mode of action of cholecystokinin octapeptide on smooth muscles of stomach, ileum and gall bladder. Methods and Findings in Experimental and Clinical Pharmacology 8:697–703
Rattan S, Goyal RK (1983) Pharmacological differences between neural (inhibitory) and muscle (excitatory) CCK receptors in the cat lower esophageal sphincter (Abstr). Gastroenterology 84:1281
Regoli D (1982) Vascular receptors for polypeptides. Trends Pharmacol Sci 3: 286–288
Regoli D (1987) Peptides, receptors, antagonists. TIPS 8: Centrefold January issue
Regoli D, Nantel F (1990) Receptor-independent action of bradykinin. Direct activation of G proteins. Trends Pharmacol Sci 11:400–401
Regoli Nantel F (1991) Pharmacology of neurokinin receptors. Biopolymers
Regoli D, Escher E, Drapeau G, D’Orléans-Juste P, Mizrahi J (1984) Receptors for substance P. III. Classification by competitive antagonists. Eur J Pharmacol 97:179–189
Regoli D, Drapeau G, Dion S, D’Orléans-Juste P (1987) Pharmacological receptors for substance P and neurokinins. Life Sci 40:109–117
Regoli D, Drapeau G, Dion S, Couture R (1988) New selective agonists for neurokinin receptors: pharmacological tools for receptor characterization. Trends Pharmacol Sci 9:290–295
Regoli D, Dion S, Rhaleb NE, Drapeau G, Rouissi N, D’Orléans-Juste P (1989a) Receptors for neurokinins, tachykinins and bombesin: a pharmacological study Ann NY Acad Sci 547:158–173
Regoli D, Drapeau G, Dion S, D’Orléans-Juste P (1989b) Receptors for substance P and related neurokinins. A mini-review. Pharmacology 38:1–15
Regoli D, Rhaleb NE, Dion S, Tousignant C, Rouissi NE, Jukic D, Drapeau G (1990a) Neurokinin A. A pharmacological study. Pharmacol Res 22:1–14
Regoli D, Rhaleb NE, Dion S, Drapeau G (1990b) New selective bradykinin receptor antagonists and bradykinin B2 receptor characterization. Trends Pharmacol Sci 11:156–161
Rehfeld JF (1986) Accumulation of nonamidated preprogastrin and preprocho-lecystokinin products in porcine pituitary corticotrophs. J Biol Chem 261: 5841–5847
Renfeld JF, Hansen HF, Marley PD, Stenjard-Pedersen K (1985) Molecular forms of cholecystokinin in the brain and the relationship to neuronal gastrin Ann N Y Acad Sci 448:11–23
Resin H, Stern DH, Sturdevant R, Isenberg JL (1973) Effect of the C-terminal of cholecystokinin on lower esophageal sphincter pressure in man. Gastroenterology 64:946–949
Rioux F, Park WK, Regoli D (1973) Application of drug-receptor theories to angiotensin. Can J Physiol Pharmacol 51:665–672
Rioux F, Quirion R, Regoli D, Leblanc MA, St-Pierre S (1980) Possible interactions between neurotensin and prostaglandins in the isolated rat portal vein Life Sci 27:259–267
Rioux F, Lemieux M, Kerouac R, Bernoussi A, Roy G (1989) Local application of neurotensin to abdominal organs triggers cardiovascular reflexes in guinea pigs: possible mechanisms. Peptides 10:647–655
Rodgers DF, Aursudkij B, Barnes PJ (1989) Effects of tachykinins on mucus secretion in human bronchi in vitro. Eur J Pharmacol 174: 283–286
Rogers J, Hughes RG, Mathews EK (1988) Cyclic GMP inhibits protein kinase C-mediated secretion in rat pancreatic acini. J Biol Chem 263:3713–3719
Rökaeus A (1991) Regulation of gastrointestinal neuropeptide gene expression and processing. In: Daniel EE (ed) Neuropeptide function in the gastrointestinal tract. CRC, Boca Raton, pp 87–129
Rollandy I, Guillemain I, Imhoff V, Drapeau G, Regoli D, Rossignol B (1991) Involvement of NK-1 receptors and importance of the N-terminal sequence of substance P in the stimulation of protein secretion in rat parotid glands. Eur J Pharmacol 209:95–100
Roques BP, Beaumont A (1990) Neutral endopeptidase-24.11 inhibitors: from analgesics to antihypertensives? Trends Pharmacol Sci 11:245–249
Roques BP, Fournie-Zaluski MC (1986) Enkephalin-degrading enzyme inhibitors: a physiological way to new analgesics and psychoactive agents. NIDA Res Monogr Ser 70:128–154
Roques BP, Fournié-Zaluski MC, Soroca E, Lecomte JH, Malfroy B, Llorens C, Schwartz JC (1980) The enkephalinase inhibitor thiorphan shows anti nociceptive activity in mice. Nature 288:286–288
Rosell S (1977) Actions of neurotensin and [Gln4]-neurotensin on isolated tissues. Acta Pharmacol Toxicol (Copenh) 41:141–147
Rossie SS, Miller RJ (1982) Regulation of mast cell histamine release by neuro-tensine. Life Sci 31:509–516
Rouissi N, Nantel F, Drapeau G, Rhaleb N-E, Dion S, Regoli D (1990a) Inhibitors of peptidases: how they influence the biological activities of substance P, neurokinins, bradykinin and angiotensin in guinea pig, hamster and rat urinary bladders. Pharmacology 40:196–204
Rouissi N, Nantel F, Drapeau G, Rhaleb NE, Dion S, Regoli D (1990b) Inhibitors of peptidases: how they influence the biological activities of substance P, neurokinins, kinins and angiotensins in isolated vessels. Pharmacology 40:185–195
Rouissi N, Rhaleb NE, Nantel F, Dion S, Drapeau G, Regoli D (1991a) Characterization of bombesin receptors in peripheral contractile organs. Brit J Pharmacol 103:1141–1147
Rouissi N, Gitter BD, Waters DC, Howbert JJ, Nixon JA, Regoli D (1991b) Selectivity and specificity of new, non peptide, quinuclidine antagonists of substance P. Biochem Biophys Res Commun 176:894–901
Rozengurt E (1988) Bombesin-induction of cell prolipheration in 3T3 cells: specific receptors and early signaling events. Ann NY Acad Sci 547:277–292
Salem H, Aviasto DM (eds) (1970) Antitussive agents, vols 1–3. Pergamon, Oxford International encyclopedia of pharmacology and therapeutics, sect 27
Sausville EA, Moyer JD, Heikkila R, Neckers LM, Trepel JB (1988) A correlation of bombesin responsiveness with myc-family gene expression in small cell lung carcinoma cell lines. Ann NY Acad Sci 547:310–321
Sasai Y, Nakanishi S (1989) Molecular characterisation of rat substance K receptors and its mRNAs. Biochem Biophys Res Commun 165:695–702
Schang JC, Hemond M, Hebert M, Pilote M (1986) How does morphine work on colonic motility? An electro myographic study in the human left and sigmoid colon. Life Sci 38:671–676
Scheurer UL, Varga L, Drack E, Burk HR, Halter F (1983) Mechanisms of action of CCK-octapeptide on rat antrum pylorus and duodenum. Am J Physiol 244: G266–G272
Schild HO (1947) pAx, a new scale for the measurement of drug antagonism. Br J Pharmacol 2:189–206
Schutzberg M, Hökfelt T, Lundberg JM (1982) Co-existence of classical transmitters and peptides in the central and peripheral nervous system. Br Med Bull 38: 309–318
Selbekk BH, Flaten O, Hanssen LE (1980) The in vitro effect of neurotensin on human jejunum mast cells. Scand J Gastroenterol 15:457–460
Severi C, Grider JR, Makhlouf GH (1988) Identification of separate bombesin and substance P precursors on isolated muscle cells from canine gallbladder. J Pharmacol Exp Ther 245:195–198
Shigemoto R, Yokota Y, Tsuchida K, Nakanishi S (1990) Cloning and expression of rat neuromedin K receptor cDNA. J Biol Chem 265:623–628
Smith GM, Lowenstein E, Hubbard JH, Beecher HK (1968) Experimental pain produced by the submaximum effort tourniquet technique: further evidence of validity. J Pharmacol Exp Ther 163:468–474
Snider RM, Constantine JW, Lowe JA, III Longo KP, Lebel WS, Woody HA, Drozda SE, Desai MC, Vinick FJ, Spencer RW, Hess HJ (1991) A potent non peptide antagonist of the substance P (NK-1) receptor. Science 251:435–437
Spindel ET, Zilberberg MD, Habener JF, Chin WW (1986) Two prohormones for gastrin releasing peptide are encoded by two mRNAs differing by 19 nucleotides. Proc Natl Acad Sci USA 83:19–23
Spindel ET, Giladi E, Brehm P, Goodman RH, Segerson TP (1990) Cloning and functional characterization of a complementary DNA encoding the murine fibroblast bombesin/gastrin-releasing peptide receptor. Mol Endocrinol 4:1956–1963
St-Pierre S, Kerouac R, Quirion R, Jolicoeur FB, Rioux F (1984) Neurotensin. Pept Protein Rev 2:83–171
Studer RO, Trzeciak A, Lergier W (1973) Isolierung und Aminosäuresequenz von Substanz P aus Pferdedarm. Helv Chim Acta 56:860–866
Sutter MC (1990) The mesenteric-portal vein in research. Pharmacol Rev 42:287–325
Taché Y (1988) Summary and concluding remarks. Bombesin-like peptides in health and disease. Ann NY Acad Sci 547:429–437
Takahashi Y, Kato K, Hayashizaki Y, Wakabayashi T, Ohtsuka E, Matsuki S, Ikehara M, Matsubara K (1985) Molecular cloning of the human cholecystokinin gene by use of a synthetic probe containing deoxynosine. Proc Natl Acad Sci USA 82:1931–1935
Takemori AE, Portoghese PS (1985) Receptors for opioid peptides in the guinea pig ileum. J Pharmacol Exp Ther 235:389–392
Takemoto K, Lundberg JM, Jörnvall H, Mutt V (1985) Neuropeptide K: isolation, structure and biological activities of a novel brain tachykinin. Biochem Biophys Res Commun 128:947–953
Tanaka K, Masu M, Nakanishi S (1990) Structure and functional expression of the cloned rat neurotensin receptor. Neuron 4:847–854
Tousignant C, Dion S, Drapeau G, Regoli D (1987) Characterization of pre and postfunctional receptors for kinins and neurokinins in the rat vas deferens. Neuropeptides 9:333–343
Ueda N, Muramatsu I, Taniguchi T, Nakanishi S, Fujiwaea M (1986) Effects of neurokinin A, substance P and electrical stimulation on the rabbit iris sphincter muscle. J Pharmacol Exp Ther 239:494–499
Valenzuela JE (1976) Effect of intestinal hormones and peptides on intragastric pressure in dogs. Gastroenterology 71:766–769
Varner AA, Modlin IM, Walsh JH (1981) High potency of bombesin for stimulation of human gastrin release and gastric acid secretion. Regul Pept 1:289–296
Vizi ES, Bertaccini G, Impicciatore M, Knoll J (1972) Acetylcholine-releasing effect of gastrin and related polypeptides. Eur J Pharmacol 17:175–178
Von Euler US (1936) Preparation of substance P. Scand Arch Physiol 73:142–144
Von Euler US, Gaddum JH (1931) An unidentified depressor substance in certain tissue extracts. J Physiol (Lond) 72:74–87
Wado E, Way J, Shapira H, Kusano K, Lebacq-Verheyden AM, Coy D, Jensen R, Battery J (1991) cDNA cloning, characterization and brain region specific expression of a neuromedin-B preferring bombesin receptor. Neuron 6:421–430
Walsh JH (1987) Gastrointestinal hormones - cholecystokinin. In: Johnson LR (ed) Physiology of the gastrointestinal tract. Raven, New York, p 195
Wamsley JK (1983) Opioid receptors: autoradiography. Pharmacol Rev 35:69–83
Watkins LR, Kinscheck IB, Mayer DJ (1985) Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide. Brain Res 327:169–180
Watson SJ, Akil H, Ghazarossian VE, Goldstein A (1981) Dynorphin immunocytochemicals localization in brain and peripheral nervous sytem: preliminary studies. Proc Natl Acad Sci USA 78:1260–1263
Watson SJ (1984) The action of substance P on contraction, inositol phospholipids and adenylate cyclase in rat small intestine. Biochem Pharmacol 33:3733–3737
Widerlöv E, Lindstrom LH, Besev G, Manberg PJ, Nemeroff CB, Breese GR, Kizer JS, Prange AJ (1982) Subnormal CSF levels of neurotensin in a subgroup of schizophrenic patients: normalization after neuroleptic treatment. Am J Psychiatry 139:1122–1126
Williams JA, McChesney DJ, Calayag MC, Lingappa VR, Logsdon CD (1988) Expression of receptors for cholecystokinin and other Ca2+ mobilizing hormones in xenopus oocytes. Proc Natl Acad Sci USA 85:4939–4943
Wolfe M, McGuigan JE (1984) Immunochemical characterization of gastrin and cholecystokininlike peptides released in dogs in response to a peptone meal. Gastroenterology 87:323–334
Woodruff GN, Hughes J (1991) Cholecystokinin antagonists. Annu Rev Pharmacol Toxicol 31:469–501
Wuster M, Schulz R, Herz A (1980) The direction of opioids agonists towards μ, δ and κ receptors in the vas deferens of the mouse and the rat. Life Sci 27:163–170
Yaksh TL, Jessel TM, Gamse R, Mudge AW, Leeman E (1980) Intrathecal morphine inhibits substance P release from mammalian spinal cord. Nature 286:155–157
Yamamoto Y, Holts K, Matanota T (1984) Effect of methionine-enkephalin on the spontaneous electrical and mechanical activity of the smooth muscle of the rat portal vein. Life Sci 34:993–999
Yamamura T, Takahashi T, Kusonoki M, Kantoh M, Ishikawa Y, Utsunomiya J (1986) Cholecystokinin octapeptide-evoked [3H] acetylcholine release from guinea pig gall bladder. Neurosci Lett 65:167–170
Yau WM, Makhlouf GM, Edwards LE, Ferrar JT (1973) Mode of action of cholecystokinin and related peptides on gall bladder muscle. Gastroenterology 65:451–456
Yau WM, Makhlouf GM, Edwards LE, Farrar JT (1974) The action of cholecystokinin and related peptides on guinea pig small intestine. Can J Physiol Pharmacol 52:298–303
Yau WM, Lingle PF, Youther ML (1983) Interaction of enkephalin and caerulein on guinea pig small intestine. Am J Physiol 244:G65–G70
Yokota Y, Sasai Y, Tanaka K, Fujiwara T, Tsuchida K, Shigemato R, Kakiguka A, Ohkubo H, Nakanishi S (1989) Molecular characterization of a functional cDNA for rat ésubstance P receptor. J Biol Chem 264:17649–17652
Yu DH, Huang SC, Wank SA, Mantey S, Gardner JD, Jensen RT (1990) Pancreatic receptors for cholecystokinin: evidence for three receptor classes. Am J Physiol 258:G86–G95
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Regoli, D., Rouissi, N., D’Orléans-Juste, P. (1994). Neuropeptides (Neurokinins, Bombesin, Neurotensin, Cholecystokinins, Opioids) and Smooth Muscle. In: Szekeres, L., Papp, J.G. (eds) Pharmacology of Smooth Muscle. Handbook of Experimental Pharmacology, vol 111. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78920-5_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-78920-5_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-78922-9
Online ISBN: 978-3-642-78920-5
eBook Packages: Springer Book Archive